The UC Davis School of Medicine will expand its successful three-year medical school pathway into Northern California rural ...

Syndeio Biosciences, a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders, today announced the appointment of Aaron Koenig, M.D., as ...

Lyon College biology majors Emily Berry and Hannah Davison spent their summer deepening their understanding of public health ...

Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch timing of its experimental psilocybin-based depression therapy by 9 to 12 months.

November and December are often synonymous with travel. Whether taking a brief road trip or flying across the country, a ...